DeepMed Research

University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Ghrelin in Healthy and Frail Older Women

Phase 1

Completed

Conditions: Frailty

Interventions: Drug: Ghrelin Infusion - Healthy
Drug: Ghrelin Infusion - Frail
Other: Placebo Infusion -Healthy
Other: Placebo Infusion - Frail

First Posted Date: 2007-08-27

Last Posted Date: 2019-06-13

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 10

Registration Number: NCT00520884

Locations: 🇺🇸
University of Pennsylvania Clinical and Translational Research Center, Philadelphia, Pennsylvania, United States

Evaluating the Effectiveness of Financial Incentives in Promoting Weight Loss Among Obese Individuals.

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Financial Incentives

First Posted Date: 2007-08-24

Last Posted Date: 2015-06-11

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 57

Registration Number: NCT00520611

Locations: 🇺🇸
Center for Health Equity Research and Promotion, Philadelphia, Pennsylvania, United States

Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations

Phase 1

Active, not recruiting

Conditions: Amaurosis of Leber
Retinal Diseases

Interventions: Genetic: rAAV2-CBSB-hRPE65

First Posted Date: 2007-06-01

Last Posted Date: 2024-07-24

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 15

Registration Number: NCT00481546

Locations: 🇺🇸
Shands Children's Hospital, University of Florida, Gainesville, Florida, United States
🇺🇸
Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States

Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal

Phase 2

Completed

Conditions: Marijuana Dependence

Interventions: Drug: Dronabinol
Behavioral: BRENDA therapy
Drug: Placebo

First Posted Date: 2007-05-31

Last Posted Date: 2019-07-29

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 61

Registration Number: NCT00480441

Locations: 🇺🇸
Treatment Research Center at the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients

Phase 1

Completed

Conditions: Ovarian Cancer
Primary Peritoneal Carcinoma
Fallopian Tube Cancer

Interventions: Biological: DC-Ova
Biological: DC Ova with Cyclophosphamide

First Posted Date: 2007-05-24

Last Posted Date: 2019-10-23

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 14

Registration Number: NCT00478452

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Ovarian Cancer and Immune Response to Flu Vaccine

Completed

Conditions: Ovarian Cancer

First Posted Date: 2007-05-24

Last Posted Date: 2016-10-05

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 37

Registration Number: NCT00478387

Locations: 🇺🇸
Department of Obstetrics and Gynecology, Division of GYN Oncology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis

Phase 1

Completed

Conditions: Wegener's Granulomatosis

Interventions: Drug: Abatacept

First Posted Date: 2007-05-02

Last Posted Date: 2016-01-18

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 20

Registration Number: NCT00468208

Locations: 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸
Boston University School of Medicine, Boston, Massachusetts, United States
🇺🇸
Mayo Clinic College of Medicine, Rochester, Minnesota, United States

and more 1 locations

Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation

Recruiting

Conditions: Primary Graft Dysfunction
Lung Transplantation

First Posted Date: 2007-04-09

Last Posted Date: 2024-07-05

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 1150

Registration Number: NCT00457847

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

HIV Prevention Among Substance Abusing SMI

Phase 3

Completed

Conditions: Substance Abuse
Mentally Ill Persons
HIV Infections

Interventions: Behavioral: PATH

First Posted Date: 2007-03-15

Last Posted Date: 2015-12-03

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 238

Registration Number: NCT00447720

Locations: 🇺🇸
Hall Mercer Community Mental Health Clinic, Philadelphia, Pennsylvania, United States

Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant

Phase 1

Completed

Conditions: B-cell Lymphoma
Non-Hodgkin's Lymphoma

First Posted Date: 2007-02-13

Last Posted Date: 2016-08-17

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 16

Registration Number: NCT00434629

Locations: 🇺🇸
Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy